Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intratumor ethanol injection

K Okuda1

  • 1Department of Medicine, Chiba University Hospital, Japan.

Journal of Surgical Oncology. Supplement
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Intratumor ethanol injection therapy is a treatment for hepatocellular carcinoma. It is a preferred option for patients with small, few tumors who have poor surgical risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[A case report of double bile duct].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology·1992
Same author

[Clinical effects of six-month short time biofiltration].

Nihon Jinzo Gakkai shi·1992
Same author

[Historical aspects of clinical enzymology].

Rinsho byori. The Japanese journal of clinical pathology·1992
Same author

The relationship between polysaccharide antigen and interleukin-1 beta producing activity in Porphyromonas gingivalis.

The Bulletin of Tokyo Dental College·1992
Same author

Diagnosis of typhus infection with Rickettsia tsutsugamushi by polymerase chain reaction.

Journal of medical microbiology·1992
Same author

Purification and characterization of 7 alpha-hydroxy-4-cholesten-3-one 12 alpha-hydroxylase.

The Journal of biological chemistry·1992
Same journal

XII National Congress of the Italian Polyspecialistic Society of the Young Surgeons (SPIGC). 20-22 May 1999. Abstracts.

Journal of surgical oncology. Supplement·1999
Same journal

Studies in vitro on the influence of ursodeoxycholate sodium salt (UDC) on hepatocyte proliferation.

Journal of surgical oncology. Supplement·1993
Same journal

Surgical risk in alcoholic cirrhotic postmenopausal women: prognostic value of levels of hormones.

Journal of surgical oncology. Supplement·1993
Same journal

Preoperative evaluation of a patient for hepatic surgery.

Journal of surgical oncology. Supplement·1993
Same journal

Tumor cell adhesion receptors.

Journal of surgical oncology. Supplement·1993
Same journal

Molecular mechanisms of protease-mediated tumor invasiveness.

Journal of surgical oncology. Supplement·1993
See all related articles

Area of Science:

  • Hepatobiliary Medicine
  • Interventional Oncology

Background:

  • Hepatocellular carcinoma (HCC) is a primary liver cancer with significant global impact.
  • Treatment options for HCC include resection, transplantation, ablation, and systemic therapies.
  • Minimally invasive techniques are crucial for managing unresectable or high-risk HCC patients.

Purpose of the Study:

  • To review the development, principles, indications, and techniques of intratumor ethanol injection (IEI) for HCC.
  • To present the authors' experience with IEI in 125 HCC patients.
  • To evaluate IEI as a therapeutic option for specific HCC patient subgroups.

Main Methods:

  • Historical review of intratumor ethanol injection therapy for HCC.
  • Description of the underlying principles and procedural techniques.

Related Experiment Videos

  • Retrospective analysis of clinical data from 125 treated HCC patients.
  • Main Results:

    • Intratumor ethanol injection therapy has evolved as a treatment modality for HCC.
    • The therapy is particularly suitable for small, limited hepatocellular carcinoma lesions.
    • Patients with poor surgical risk may benefit from this minimally invasive approach.

    Conclusions:

    • Intratumor ethanol injection is a valuable therapeutic option for selected HCC cases.
    • It offers a viable alternative for patients unsuitable for surgical resection.
    • Further research can refine the application of IEI in hepatocellular carcinoma management.